Martin Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-73,472
| Closed | -$5.33M | – | 51 |
|
|
2021
Q4 | $5.33M | Sell |
73,472
-12,302
| -14% | -$847K | 1.32% | 31 |
|
|
2021
Q3 | $5.99M | Sell |
85,774
-1,183
| -1% | -$83.1K | 1.51% | 28 |
|
|
2021
Q2 | $5.99M | Sell |
86,957
-996
| -1% | -$66.5K | 1.54% | 27 |
|
|
2021
Q1 | $5.68M | Buy |
87,953
+10,389
| +13% | +$670K | 1.61% | 26 |
|
|
2020
Q4 | $4.52M | Sell |
77,564
-1,552
| -2% | -$93.6K | 1.44% | 30 |
|
|
2020
Q3 | $5M | Buy |
79,116
+3,295
| +4% | +$228K | 1.8% | 25 |
|
|
2020
Q2 | $5.83M | Sell |
75,821
-278
| -0.4% | -$21.3K | 2.43% | 19 |
|
|
2020
Q1 | $5.69M | Sell |
76,099
-19,485
| -20% | -$1.35M | 2.88% | 11 |
|
|
2019
Q4 | $6.21M | Sell |
95,584
-55,186
| -37% | -$3.59M | 2.16% | 27 |
|
|
2019
Q3 | $9.56M | Buy |
150,770
+15,586
| +12% | +$1.02M | 2.34% | 27 |
|
|
2019
Q2 | $9.13M | Sell |
135,184
-1,804
| -1% | -$119K | 2.3% | 26 |
|
|
2019
Q1 | $8.91M | Buy |
136,988
+32
| +0% | +$2.13K | 2.32% | 28 |
|
|
2018
Q4 | $8.57M | Sell |
136,956
-2,200
| -2% | -$154K | 2.76% | 19 |
|
|
2018
Q3 | $10.7M | Sell |
139,156
-26,842
| -16% | -$2.03M | 2.88% | 17 |
|
|
2018
Q2 | $11.8M | Buy |
165,998
+4,897
| +3% | +$346K | 2.96% | 16 |
|
|
2018
Q1 | $12.1M | Buy |
161,101
+14,540
| +10% | +$1.16M | 3.08% | 14 |
|
|
2017
Q4 | $11.9M | Hold |
146,561
| – | – | 3.32% | 11 |
|
|
2017
Q3 | $11.9M | Buy |
146,561
+2,296
| +2% | +$176K | 3.32% | 11 |
|
|
2017
Q2 | $10.2M | Buy |
144,265
+3,380
| +2% | +$225K | 2.88% | 24 |
|
|
2017
Q1 | $9.57M | Sell |
140,885
-56,415
| -29% | -$3.97M | 2.7% | 25 |
|
|
2016
Q4 | $14.1M | Sell |
197,300
-40,901
| -17% | -$3.04M | 2.68% | 19 |
|
|
2016
Q3 | $18.8M | Buy |
238,201
+3,983
| +2% | +$324K | 3.1% | 15 |
|
|
2016
Q2 | $19.5M | Sell |
234,218
-31,413
| -12% | -$2.79M | 3.26% | 17 |
|
|
2016
Q1 | $24.4M | Sell |
265,631
-7,617
| -3% | -$687K | 3.81% | 5 |
|
|
2015
Q4 | $27.6M | Sell |
273,248
-17,670
| -6% | -$1.84M | 4.39% | 5 |
|
|
2015
Q3 | $28.6M | Sell |
290,918
-29,794
| -9% | -$3.31M | 4.61% | 3 |
|
|
2015
Q2 | $37.5M | Sell |
320,712
-4,779
| -1% | -$522K | 5.38% | 2 |
|
|
2015
Q1 | $31.9M | Buy |
325,491
+48,577
| +18% | +$4.93M | 4.46% | 4 |
|
|
2014
Q4 | $26.1M | Buy |
276,914
+1,982
| +0.7% | +$205K | 4.3% | 4 |
|
|
2014
Q3 | $29.3M | Sell |
274,932
-33,228
| -11% | -$3.25M | 5.17% | 2 |
|
|
2014
Q2 | $25.6M | Buy |
308,160
+55
| +0% | +$4.28K | 4.59% | 3 |
|
|
2014
Q1 | $21.8M | Sell |
308,105
-3,953
| -1% | -$310K | 4.15% | 6 |
|
|
2013
Q4 | $23.4M | Buy |
312,058
+8,274
| +3% | +$576K | 4.32% | 4 |
|
|
2013
Q3 | $19.1M | Buy |
303,784
+144
| +0% | +$8.61K | 4.15% | 4 |
|
|
2013
Q2 | $15.5M | Buy |
+303,640
| New | +$15.8M | 3.68% | 9 |
|
Other funds holding GILD
Martin Investment Management's GILD Position: Q1 2022 in Review
Martin Investment Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 73,472 shares — an estimated $5.33M sold.
Martin Investment Management first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $37.5M in Q2 2015. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Martin Investment Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Martin Investment Management sold 73,472 Gilead Sciences shares in Q1 2022, an estimated $5.33M.
- Martin Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- Martin Investment Management's Gilead Sciences position peaked at $37.5M in Q2 2015.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Martin Investment Management's 13F filing for Q1 2022, filed 10 May 2022.